Michael M. Goldberg is President at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB). They have made 1 open-market trade across 1 company since 2014, most recently 2017-05-16.
CIK 0000905011
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $108K since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NAVB | BUY | 2014-11-13 | 2014-11-17 | $1.08 | $108K | -10.6% | -5.1% | -5.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.